C4 Therapeutics' GAAP loss for 2021 was $83.892 million, up 26.5% from $66.335 million in the prior year. Revenue increased 37.9% to $45.785 million from $33.195 million a year earlier.
C4 Therapeutics' GAAP loss for 2021 was $83.892 million, up 26.5% from $66.335 million in the prior year. Revenue increased 37.9% to $45.785 million from $33.195 million a year earlier. 
ir.c4therapeutics.com
English (US) 